Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cuthbertson

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Diabetes|July 27, 2001
Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1L Yu, D D Cuthbertson, N Maclaren, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|January 19, 2002
Utility of duplex surveillance following iliac artery angioplasty and primary stentingM R Back, M Novotney, S M Roth, et al.
Bone|May 1, 2021
Alterations of a serum marker of collagen X in growing children with osteogenesis imperfectaL E Nicol, R F Coghlan, D Cuthbertson, et al.
Diabetologia|December 17, 2004
High frequency of abnormal glucose tolerance in DQA1*0102/DQB1*0602 relatives identified as part of the Diabetes Prevention Trial--Type 1 DiabetesC J Greenbaum, G Eisenbarth, M Atkinson, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1995
Age and family relationship accentuate the risk of insulin-dependent diabetes mellitus (IDDM) in relatives of patients with IDDMA B Cantor, J P Krischer, D D Cuthbertson, et al.
Orphanet Journal of Rare Diseases|January 31, 2019
Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot studyLaura L Tosi, Marianne K Floor, Christina M Dollar, et al.
The Journal of Pediatrics|February 15, 2001
First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetesH P Chase, D D Cuthbertson, L M Dolan, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetesJeffrey P Krischer, David D Cuthbertson, Liping Yu, et al.
Science (New York, N.Y.)|August 31, 2019
Redox-neutral organocatalytic Mitsunobu reactionsRhydian H Beddoe, Keith G Andrews, Valentin Magné, et al.
Molecular Genetics and Metabolism Reports|December 18, 2020
Zellweger spectrum disorder: A cross-sectional study of symptom prevalence using input from family caregiversMousumi Bose, David D Cuthbertson, Marsha A Fraser, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Diabetes|July 27, 2001
Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1L Yu, D D Cuthbertson, N Maclaren, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|January 19, 2002
Utility of duplex surveillance following iliac artery angioplasty and primary stentingM R Back, M Novotney, S M Roth, et al.
Bone|May 1, 2021
Alterations of a serum marker of collagen X in growing children with osteogenesis imperfectaL E Nicol, R F Coghlan, D Cuthbertson, et al.
Diabetologia|December 17, 2004
High frequency of abnormal glucose tolerance in DQA1*0102/DQB1*0602 relatives identified as part of the Diabetes Prevention Trial--Type 1 DiabetesC J Greenbaum, G Eisenbarth, M Atkinson, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1995
Age and family relationship accentuate the risk of insulin-dependent diabetes mellitus (IDDM) in relatives of patients with IDDMA B Cantor, J P Krischer, D D Cuthbertson, et al.
Orphanet Journal of Rare Diseases|January 31, 2019
Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot studyLaura L Tosi, Marianne K Floor, Christina M Dollar, et al.
The Journal of Pediatrics|February 15, 2001
First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetesH P Chase, D D Cuthbertson, L M Dolan, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetesJeffrey P Krischer, David D Cuthbertson, Liping Yu, et al.
Science (New York, N.Y.)|August 31, 2019
Redox-neutral organocatalytic Mitsunobu reactionsRhydian H Beddoe, Keith G Andrews, Valentin Magné, et al.
Molecular Genetics and Metabolism Reports|December 18, 2020
Zellweger spectrum disorder: A cross-sectional study of symptom prevalence using input from family caregiversMousumi Bose, David D Cuthbertson, Marsha A Fraser, et al.
Pageof 6